Archive

Successful penicillin allergy de-labelling

Written by Christine Clark | 24 Mar 2025

29th EAHP Congress highlights Approximately 10% of inpatients are labelled as ‘allergic to penicillin’ but the vast majority have not experienced a true allergic reaction. Having a penicillin… read more.

Evidence-based approaches to penicillin allergy de-labelling

Written by Christine Clark | 17 Nov 2023

Neil Powell combines the roles of consultant antimicrobial pharmacist and clinical researcher at the Royal Cornwall Hospital in Truro. In this series of short videos, he describes the… read more.

What does a consultant antimicrobial pharmacist do?

Written by Christine Clark | 16 Nov 2023

The work of a consultant antimicrobial pharmacist involves not only knowing about antimicrobial medicines but also understanding how people and organisations behave and collaborating with others to optimise… read more.

Could penicillin allergy de-labelling lead to better outcomes?

Written by Christine Clark | 15 Nov 2023

Implementation of penicillin allergy de-labelling calls for an understanding of the key barriers and enablers in healthcare systems – topics that the iNAAN and ALABAMA studies address, explains… read more.

What the PALACE study tells us about penicillin allergy de-labelling

Written by Christine Clark | 14 Nov 2023

The PALACE study showed that in people at low-risk of penicillin allergy, a direct oral challenge with penicillin was no less effective than standard allergy testing for determining… read more.

Why penicillin allergy labels might be a bad thing

Written by Christine Clark | 13 Nov 2023

Neil Powell combines the roles of a consultant antimicrobial pharmacist and a clinical researcher at the Royal Cornwall Hospital in Truro. His current research is focused on the… read more.